1. Botanical-Be recalls dietary supplements with undeclared diclofenac

   News item 11 November 2023 Pages: 1 - 1

2. Exela Pharma Sciences recalls injectable products due to particulates

   News item 11 November 2023 Pages: 2 - 2

3. FDA warns against use of OTC lubricating eye drops

   News item 11 November 2023 Pages: 3 - 3

4. Fosamax- and Fosavance-related low-energy fracture

   News item 11 November 2023 Pages: 4 - 4

5. Health Canada seizes unauthorised health products from UU Zone

   News item 11 November 2023 Pages: 5 - 5

6. Increase in falsified semaglutide detained in Ireland

   Media release 11 November 2023 Pages: 6 - 6

7. New safety measures for use of isotretinoin in adolescents in the UK

   News item 11 November 2023 Pages: 7 - 7

8. Risk of medication errors with use of UK-authorised potassium chloride

   News item 11 November 2023 Pages: 8 - 8

9. Safety of vaccinations in Canada during 2022

   News item 11 November 2023 Pages: 9 - 9

10. Meningococcal group B vaccine increases risk of fever in infants

    Clinical study 11 November 2023 Pages: 10 - 10

11. Mycophenolate mofetil-related diarrhoea in allo-HSCT recipients

    Clinical study 11 November 2023 Pages: 11 - 11

12. Small intestinal bacterial overgrowth after short-term PPI use

    Clinical study 11 November 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 11 November 2023 Pages: 13 - 13

14. Abemaciclib

    Case report 11 November 2023 Pages: 14 - 14

15. Abemaciclib

    Case report 11 November 2023 Pages: 15 - 15

16. Acalabrutinib/ibrutinib/venetoclax

    Case report 11 November 2023 Pages: 16 - 16

17. Aciclovir/varicella-zoster-virus-vaccine

    Case report 11 November 2023 Pages: 17 - 17

18. Adalimumab/anakinra

    Case report 11 November 2023 Pages: 18 - 18

19. Adalimumab/etanercept/tocilizumab

    Case report 11 November 2023 Pages: 19 - 19

20. Alectinib/cisplatin/etoposide

    Case report 11 November 2023 Pages: 20 - 20

21. Alemtuzumab/furosemide/immunosuppressants

    Case report 11 November 2023 Pages: 21 - 21

22. Alendronic-acid

    Case report 11 November 2023 Pages: 22 - 22

23. Alendronic-acid

    Case report 11 November 2023 Pages: 23 - 23

24. Alendronic-acid

    Case report 11 November 2023 Pages: 24 - 24

25. Allopurinol

    Case report 11 November 2023 Pages: 25 - 25

26. Amikacin/ceftazidime/colistin

    Case report 11 November 2023 Pages: 26 - 26

27. Aminolevulinic-acid/itraconazole

    Case report 11 November 2023 Pages: 27 - 27

28. Amiodarone

    Case report 11 November 2023 Pages: 28 - 28

29. Amitriptyline

    Case report 11 November 2023 Pages: 29 - 29

30. Amoxicillin

    Case report 11 November 2023 Pages: 30 - 30

31. Ampicillin

    Case report 11 November 2023 Pages: 31 - 31

32. Analgesics/hypnosedatives

    Case report 11 November 2023 Pages: 32 - 32

33. Antibacterials

    Case report 11 November 2023 Pages: 33 - 33

34. Antibacterials/pyridoxine

    Case report 11 November 2023 Pages: 34 - 34

35. Antidepressants

    Case report 11 November 2023 Pages: 35 - 35

36. Antiepileptic drugs

    Case report 11 November 2023 Pages: 36 - 36

37. Antifungals/antirheumatics

    Case report 11 November 2023 Pages: 37 - 37

38. Antiglaucomas/bromfenac/fluorometholone

    Case report 11 November 2023 Pages: 38 - 38

39. Antineoplastic drugs

    Case report 11 November 2023 Pages: 39 - 39

40. Antineoplastics

    Case report 11 November 2023 Pages: 40 - 40

41. Antineoplastics

    Case report 11 November 2023 Pages: 41 - 41

42. Antineoplastics

    Case report 11 November 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 11 November 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 11 November 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 11 November 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 11 November 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 11 November 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 11 November 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 11 November 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 11 November 2023 Pages: 50 - 50